PT1833801E - Compostos intermediários para a preparação de antagonistas do receptor da angiotensina ii - Google Patents

Compostos intermediários para a preparação de antagonistas do receptor da angiotensina ii Download PDF

Info

Publication number
PT1833801E
PT1833801E PT05823669T PT05823669T PT1833801E PT 1833801 E PT1833801 E PT 1833801E PT 05823669 T PT05823669 T PT 05823669T PT 05823669 T PT05823669 T PT 05823669T PT 1833801 E PT1833801 E PT 1833801E
Authority
PT
Portugal
Prior art keywords
angiotensin
receptor antagonists
preparation
compounds
intermediate compounds
Prior art date
Application number
PT05823669T
Other languages
English (en)
Inventor
Adolfo Diaz Martinez
Llorenc Rafecas Jane
Antoni Riera Escale
Mireia Pasto Aguila
Marta Ecija Queralt
Original Assignee
Algry Quimica S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36602120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1833801(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Algry Quimica S L filed Critical Algry Quimica S L
Publication of PT1833801E publication Critical patent/PT1833801E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT05823669T 2004-12-22 2005-12-22 Compostos intermediários para a preparação de antagonistas do receptor da angiotensina ii PT1833801E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04106861 2004-12-22

Publications (1)

Publication Number Publication Date
PT1833801E true PT1833801E (pt) 2008-08-25

Family

ID=36602120

Family Applications (1)

Application Number Title Priority Date Filing Date
PT05823669T PT1833801E (pt) 2004-12-22 2005-12-22 Compostos intermediários para a preparação de antagonistas do receptor da angiotensina ii

Country Status (7)

Country Link
EP (1) EP1833801B9 (pt)
KR (1) KR20070089943A (pt)
AT (1) ATE397592T1 (pt)
DE (1) DE602005007384D1 (pt)
ES (1) ES2308591T3 (pt)
PT (1) PT1833801E (pt)
WO (1) WO2006067215A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012055941A1 (en) 2010-10-27 2012-05-03 Krka,Tovarna Zdravil, D. D., Novo Mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
DE69233208T2 (de) * 1991-11-18 2004-07-08 E.I. Du Pont De Nemours And Co., Wilmington Tetrazolylphenylborsäureintermediate zur synthese von aii rezeptor antagonisten
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
PT1509517E (pt) * 2003-01-16 2008-08-05 Teva Pharma Nova síntese de irbesartan

Also Published As

Publication number Publication date
WO2006067215A2 (en) 2006-06-29
EP1833801A2 (en) 2007-09-19
DE602005007384D1 (de) 2008-07-17
WO2006067215A3 (en) 2006-11-09
ATE397592T1 (de) 2008-06-15
KR20070089943A (ko) 2007-09-04
EP1833801B1 (en) 2008-06-04
EP1833801B9 (en) 2009-02-25
ES2308591T3 (es) 2008-12-01

Similar Documents

Publication Publication Date Title
WO2007109456A3 (en) Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists
NO20060729L (no) Fremgangsmate for fremstilling av tetrazolderivater fra organiske bor- og aluminiumsazider
MX2007009282A (es) Nuevos procesos para la preparacion de un 2h-cromeno.
TW200800964A (en) Phthalazinone derivatives
Nishida et al. Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers
BRPI0519597A2 (pt) derivados de (3r, 6r)-3-(2, 3-diidro-1h-inden-2-il)-2, 5-piperazinadiona 1, 6-substituÍda como antagonistas de receptores de oxitocina para o tratamento de parto prematuro, dismenorrÉia e endometriose
NO20063380L (no) Triazolderivater som vasopressinantagonister
TNSN07277A1 (en) Pharmaceutical compounds
GEP20084494B (en) New heterocyclic carboxylic acid amide derivatives
TW200640869A (en) PGD2 receptor antagonists for the treatment of inflammatory diseases
WO2007011878A3 (en) Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
EA200700365A1 (ru) Производные индол-2-карбоксамидина как антагонисты nmda рецептора
GEP20104880B (en) Carboxamide derivatives as muscarinic receptor antagonists
WO2006067216A3 (en) Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan
TW200710084A (en) Process for the synthesis of organic compounds
AR064306A1 (es) Antagonistas del receptor de angiotensina ii
PT1833801E (pt) Compostos intermediários para a preparação de antagonistas do receptor da angiotensina ii
NO20075829L (no) Syntese
Wang et al. A novel and practical synthesis of substituted 2-ethoxy benzimidazole: candesartan cilexetil
WO2007025780A3 (en) Aldosterone receptor antagonists
HK1094575A1 (en) A process for the preparation of phenyltetrazole derivatives
EA200901295A1 (ru) Кристаллический 1-(циклогексилоксикарбонилокси)этил-1-((2`-цианодифенил-4-ил)метил)-2-этокси-1н-бензо[d]имидазол-7-карбоксилат и способ его получения
ATE461172T1 (de) Azetidinderivate als antagonisten des muskarinrezeptors
DK1489080T3 (da) Fremgangsmåde til frembringelse af cilostazol
NZ599218A (en) Process for the manufacture of organic compounds